Skip to main content

Advertisement

ADVERTISEMENT

Department

News Connection
05/30/2024
Paul Nicolaus
The Centers for Medicare & Medicaid Services (CMS)'s AHEAD model aims to improve population health management by awarding funding to states and promoting primary care investment and enhanced equity measures, but implementation challenges and...
The Centers for Medicare & Medicaid Services (CMS)'s AHEAD model aims to improve population health management by awarding funding to states and promoting primary care investment and enhanced equity measures, but implementation challenges and...
The Centers for Medicare &...
05/30/2024
First Report Managed Care
News Connection
05/29/2024
Dean Celia
During a recent webinar hosted by the Drug Channels Institute, Adam Fein, PhD, discussed the specifics of the Inflation Reduction Act (IRA) and its potential impacts and timeline. First Report Managed Care connected with other managed care...
During a recent webinar hosted by the Drug Channels Institute, Adam Fein, PhD, discussed the specifics of the Inflation Reduction Act (IRA) and its potential impacts and timeline. First Report Managed Care connected with other managed care...
During a recent webinar hosted...
05/29/2024
First Report Managed Care
Managed Care Q&A
05/27/2024
Jasmine Patel, Senior Principal, Patient Advocacy, Strategic Consulting at Envision Pharma Group
Jessica Krauser, Marketing Advisor, Envision Pharma Group; Founder of 5kforJK
In this interview, guest experts discuss the importance of incorporating patient voices into health care decision-making, highlighting opportunities for collaboration and enhancement in drug development and patient coverage.
In this interview, guest experts discuss the importance of incorporating patient voices into health care decision-making, highlighting opportunities for collaboration and enhancement in drug development and patient coverage.
In this interview, guest experts...
05/27/2024
First Report Managed Care

Advertisement

IPF letters
Formulary Frontlines®
05/13/2024

Reviewed by Elizabeth Volkmann, MD, MS

Reviewed by Elizabeth Volkmann, MD, M...
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive...
05/13/2024
First Report Managed Care
Managed Care Q&A
03/01/2024

Featuring John Stahl, Senior Director, Consulting at Clarivate and Matthew Arnold, Principal Analyst at Clarivate

Featuring John Stahl, Senior Director...
Experts from Clarivate discuss the evolving pharmaceutical landscape in 2024, emphasizing the need for payers to balance supporting innovative breakthrough medicines with containing health care costs.
Experts from Clarivate discuss the evolving pharmaceutical landscape in 2024, emphasizing the need for payers to balance supporting innovative breakthrough medicines with containing health care costs.
Experts from Clarivate discuss...
03/01/2024
First Report Managed Care
Conference Insider
12/07/2023
A roundup of news and research presented at AMCP Nexus in Orlando, FL, October 16-19, 2023.
A roundup of news and research presented at AMCP Nexus in Orlando, FL, October 16-19, 2023.
A roundup of news and research...
12/07/2023
First Report Managed Care

Advertisement

Formulary Frontlines®
06/20/2023
Julie Gould
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth...
06/20/2023
First Report Managed Care
Conference Insider
06/20/2023
The Academy of Managed Care Pharmacy occurred March 21-24, 2023 in San Antonio, Texas.
The Academy of Managed Care Pharmacy occurred March 21-24, 2023 in San Antonio, Texas.
The Academy of Managed Care...
06/20/2023
First Report Managed Care
Conference Insider
04/13/2023
Maria Asimopoulos
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE,...
04/13/2023
First Report Managed Care

Advertisement

Conference Insider
04/13/2023
Maria Asimopoulos
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews...
04/13/2023
First Report Managed Care

Advertisement